Assisted Reproductive Technology Market Overview, Size, Share and Forecast 2031

Comments · 14 Views

The Assisted Reproductive Technology Market in 2023 is US$ 28.55 billion, and is expected to reach US$ 55.31 billion by 2031 at a CAGR of 8.60%.

The Assisted Reproductive Technology Market in 2023 is US$ 28.55 billion, and is expected to reach US$ 55.31 billion by 2031 at a CAGR of 8.60%.

FutureWise Research published a report that analyzes Assisted Reproductive Technology Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.

Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Assisted Reproductive Technology research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.


Request a Sample Report @ Request for Assisted Reproductive Technology Market Sample


Assisted Reproductive Technology Market Segmentation:

By Procedure

·         Fresh donor

·         Fresh Non-donor

·         Frozen Donor

·         Frozen Nondonor

·         Embryo/Egg Banking

By Technology

·         In-vitro fertilization (IVF)

·         IVF with Intracytoplasmic Sperm Injection (ICSI)

·         IVF without Intracytoplasmic Sperm Injection (ICSI)

·         Artificial Insemination - Intrauterine Insemination (AI-IUI)

·         Frozen Embryo Replacement (FER)

·         Ovulation Induction (OI)

·         Donor Conception

·         Gamete Intrafallopian Transfer (GIFT)

·         Preimplantation Genetic Diagnosis (PGD)

·         Surrogacy

By Diagnosis

·         Ovulation Testing

·         Hysterosalpingography

·         Ovarian Reserve Testing

·         Genetic Testing

·         Other hormone testing

·         Imaging tests

By End User

·         Hospitals and Clinics

·         Ambulatory Surgical Centers

·         Diagnostic Centers

·         Gynecology Centers

·         Feminist Health Centers

·         IVF Centers

By Region

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA


Major players included in the Assisted Reproductive Technology Market:

·         Thermo Fisher Scientific, Inc.

·         Genea Limited

·         Cook Medical

·         Nidacon International AB

·         OvaScience Inc.

·         Vitro Life

·         Cooper Surgical Inc.

·         Merck

·         IVFtech ApS

·         Irvine scientific

·         Hamilton Thorne 

·         Cosmos Biomedical

·         Microm UK Ltd.

·         Origio

·         Cryolab Ltd.

·         Parallabs

·         European Sperm Bank

·         Bloom IVF Centre

·         Ferring Pharmaceuticals


Please visit full report of the Assisted Reproductive Technology market @ Visit Assisted Reproductive Technology Market


Competitive Landscape:

·         Tier one players - market players with a significant share of the market

·         Tier two players

·         Players with rapid growth

·         New Entries


FutureWise Key Takeaways:

        Prospects for growth

        Analysis of SWOT

        Key trends

        Key Data-points affecting market growth


Objectives of the Study:

        To provide report with an in-depth analysis of the Assisted Reproductive Technology Market By Procedure, By Technology, By Diagnosis, By End User and By Region

        To offer data-points and comprehensive data on factors affecting the market (Opportunities, drivers, and industry-specific restraints)